Muscle-invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Muscle-invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluated erlotinib as neoadjuvant and adjuvant therapy around surgery for muscle-invasive bladder cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine hydrochloride and cisplatin before surgery in patients with muscle invasive bladder cancer was termin…
-
CLINICAL_TRIALS withdrawal · 2017-03-07Clinical Trial Update: Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder [Phase 1]
A Phase 1 trial evaluating intratumoral REOLYSIN in combination with gemcitabine and cisplatin as neoadjuvant therapy for muscle-invasive bl…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer [NA]
This clinical trial evaluated the feasibility of online adaptive radiotherapy for muscle-invasive bladder cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin [Phase 2]
Phase 2 neoadjuvant gemcitabine plus weekly cisplatin for muscle-invasive bladder cancer (including patients not candidates for high-dose ci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 neoadjuvant chemotherapy trial evaluating gemcitabine, cisplatin, and sunitinib (GC-S) for muscle-invasive bladder cancer; study com…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine, carboplatin, and panitumumab (GCaP) as neoadjuvant chemotherapy for muscle-invasive bladder cancer w…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma [Phase 2]
Phase 2 study of dose-dense MVAC chemotherapy with pegfilgrastim support in patients with muscle-invasive bladder cancer; results were poste…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer [NA]
Completed safety and tolerability trial evaluating intravesical mitomycin C mixed with a TC-3 drug-retaining hydrogel device in patients wit…